AI assistant
Sending…
Passage BIO, Inc. — Director's Dealing 2021
Mar 30, 2021
34849_dirs_2021-03-29_2165fe03-dd74-4000-9bdc-bbe59cabbf1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2021-03-22
Reporting Person: Salinas Eliseo Oreste (Chief Res. & Develop Officer)
More from Passage BIO, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Director's Dealing
2026
Mar 18
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Jan 12
Director's Dealing
2026
Jan 12